<!DOCTYPE html>
<html lang="en">

<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Metabolic Syndrome</title>
  <link rel="stylesheet" href="styles7.css">
</head>

<body>

  <header>
    <h1>Alzheimer's & Metabolic Syndrome Awareness</h1>
  </header>

  <nav>
    <a href="homepagefinal.html">About Alzheimer's</a>
    <a href="mets.html">Metabolic Syndrome</a>
    <div class="dropdown">
      <a href="prevention.html">Prevention Tips</a>
      <div class="dropdown-content">
        <a href="#exercise">Exercise</a>
        <a href="#diet">Balanced Diet</a>
        <a href="#stress">Stress Management</a>
        <a href="#checkups">Regular Health Check-ups</a>
      </div>
    </div>
    <a href="homepagefinal.html">Resources</a>
  </nav>

  <section id="hero">
    <div class="hero-content">
      <h2>What is Metabolic Syndrome?</h2>
      <p>
        Metabolic syndrome is a cluster of conditions that increase the risk of heart disease, stroke, and type 2 diabetes.
        It includes abdominal obesity, high blood pressure, high blood sugar, low HDL cholesterol, and high triglycerides. Metabolic syndrome (MetS) is the collective of five co-occurring vascular risk factors; affecting 50% of adults aged over 60 years. An abnormal accumulation of amyloid and tau proteins in the brain marks the progression of AD. Amyloid is an insoluble, highly dominated β-sheet structure, that unlike other proteins, doesn’t currently have a structural, supportive, or motility role (Rambaran et al., 2008). All that’s understood mostly is that they have a pathogenic effect. Thus, a link between MetS and AD development has potential that has not yet been fully explored. For one to diagnosis metabolic syndrome, the presence of three or more body mass, dyslipidemia, impaired glucose tolerance, and hypertension related health conditions must be apparent as they increase heart disease risk.
      </p>
    </div>
  </section>

  <section id="exercise" class="content-section">
    <div class="content-container">
      <div class="text-content">
        <h2>The Link Between Metabolic Syndrome and Alzheimer's Disease</h2>
        <p>
          Research on the relationship between Metabolic Syndrome (MetS) and Alzheimer's disease (AD) is complicated and occasionally yields contradictory results. The relationship between MetS and AD neuropathology has been the subject of numerous investigations, which have produced conflicting results among scientists.
          MetS may not be a valid indicator of AD in late middle age, according to certain research, such as the New York study on a middle-aged Hispanic population. There are noticeable differences in the results, such as the negative relationship in one study between amyloid load and higher glucose levels and the lack of association in another. These discrepancies could be explained by population differences and the part glucose plays in the buildup of amyloid.
          Moreover, research on the contribution of variables like triglycerides, waist circumference, and HDL cholesterol to the pathophysiology of AD varies. For example, one study finds a substantial correlation between HDL cholesterol levels and AD pathogenesis, whereas another study finds the opposite. There is controversy around the relationship between waist circumference and cognitive decline; some research, claim no significant relationship, while others discover positive relationships.
          Studies, nevertheless, have produced results that corroborate Gomez's conclusions. For instance, studies have found higher amyloid buildup in particular brain areas and connected fasting glucose levels with the onset of AD. Similar to Gomez's findings, hypertension has also been linked to excessive amyloid buildup. These encouraging research frequently come from a variety of demographic backgrounds, supporting the theory that demographic factors might be involved.
          In conclusion, there is a complex link between MetS and AD, with inconsistent results from various investigations. These discrepancies could be caused by differences in study populations, approaches, and the particular MetS components taken into consideration. In order to gain a deeper comprehension of the intricate interactions between MetS and AD, additional study is required, with a focus on improving techniques and accounting for demographic factors.
        </p>
      </div>
      <div class="image-content">
        <img class="image" src="metsAD.png" alt="Exercise Image">
      </div>
    </div>
  </section>

  <!-- Add more content sections as needed -->

  <footer id="footer">
    <p id="datetime">&copy; 2023 Alzheimer's and Metabolic Syndrome Awareness</p>
  </footer>

  <script src="script1.js"></script>
</body>
</html>

</body>

</html>
